Trial no.:
|
PACTR201406000772338 |
Date of Approval:
|
17/02/2014 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
micro-needles mediated therapeutic monitoring |
Official scientific title |
Micro-needles-mediated transdermal glucose monitoring in comparison to fingerprick sample analysis |
Brief summary describing the background
and objectives of the trial
|
Despite of the fact that intensive treatment can greatly reduce the complications which may ensue diabetes, tight monitoring of glucose blood level, remains the corner stone of any effective medical management, especially in type 1 diabetic patients (Ahmed El-laboudi, 2013).Therefore, many research communities have spent their resources and time generously in developing new intelligent diagnostic devices for blood glucose measurement, so as to reduce hyper and hypoglycaemic incidence and complications (Scognamiglio, 2013).
Glucose monitoring methods were classified to invasive, minimally invasive, and non-invasive. Devices in the clinical settings and even Self-monitoring devices are considered to be entirely invasive methods for Glucose monitoring. However, most of minimally invasive and non-invasive techniques usually utilize ISF instead of plasma as measurement matrix (Carlos Eduardo Ferrante do Amaral, 2008).Subcutaneous Glucose sensor, was the best example that proved using ISF in TDM in the type-1 diabetic population (Kiang, et al., 2012).
Interstitial fluid, ISF, has been proposed to be the best alternative for plasma as a site of TDM. In fact, the composition of ISF highly resembles plasma composition except for the plasma protein. It contains carbohydrates, fatty acids, amino acids, in addition to micro-nutrients and drugs that capable of passing through the cell wall of the capillaries. Samples withdrawal from ISF is potentially non-invasive and painless procedure. Beside, sample preparation and analysis is much easier(Kiang, et al., 2012).
In the last decade, micro-needles were demonstrated to be efficient mechanical tool to breach the SC, in order to form micro-channels without stimulation of the under-laying pain nerves (Sivamani, et al., 2007).
Our research group work focused on the development of polymeric micro-needle array syst |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
MN |
Disease(s) or condition(s) being studied |
Diabetes,Nutritional, Metabolic, Endocrine |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Diagnosis / Prognosis |
Anticipated trial start date |
01/03/2014 |
Actual trial start date |
02/03/2014 |
Anticipated date of last follow up |
13/03/2014 |
Actual Last follow-up date |
13/03/2014 |
Anticipated target sample size (number of participants) |
14 |
Actual target sample size (number of participants) |
14 |
Recruitment status |
Not yet recruiting |
Publication URL |
|
|